Article
Endoglin: specific angiogenesis marker in long-time prognosis of patients with uveal melanoma?
Search Medline for
Authors
Published: | September 22, 2004 |
---|
Outline
Text
Objective
Endoglin(CD105) is a homodimeric membrane receptor of TGF-β in endothelial cells. Expression of endoglin and the following signalling pathway is essential for angiogenesis in ontogeny. An association was found to the prognosis in several malignancies.
Methods
35 clinicopathologically well characterized cases of primary uveal melanomas were retrospectively analyzed. The mean follow-up was 10.6 years (9-13 years). Corresponding paraffin sections were stained for Ki-67, von Willebrand factor and endoglin. The immunohistological specimens were evaluated by three independent observers totally masked to the follow-up of patients. Statistical analyses were performed including Kaplan-Meier survival curves and fitting of Log-Rank and Wilcoxon Test models.
Results
Expression of vWF revealed vascularisation of all examined specimens. Ki-67 was found in 74% (26 of 35) of the uveal melanoma samples. Moderate to high expression of endoglin was present in 13 cases (37%). These patients had a significant higher rate of death due to metastasis. Kaplan-Meier analysis resulted in significant correlation of enhanced expression to survival rate (p < 0.001).
Conclusions
Differential expression of the known markers for blood vessels underlines the necessity of careful interpretation of prognostic value in uveal melanoma. Subtyping of vessels by specific markers could facilitate selection of patients with high risk for metastasis. Association of reduced prognosis with high expression of endoglin corraborates the idea of therapeutical intervention by suppression of the TGFbeta signalling pathway in uveal melanoma.